26.11.2012 Views

Guidelines for ATC classification and DDD assignment - WHOCC

Guidelines for ATC classification and DDD assignment - WHOCC

Guidelines for ATC classification and DDD assignment - WHOCC

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

152<br />

package which is intended <strong>for</strong> one cycle, may contain e.g. three types of<br />

tablets, each designed to cover a special part of the menstrual period.<br />

Cycle packages may contain some tablets with progestogens only.<br />

Combination packages with separate tablets containing progestogens<br />

<strong>and</strong> estrogens intended to be taken together <strong>and</strong> in sequence are also<br />

classified in this group.<br />

5th levels are built up as in G03FA.<br />

Hormonal contraceptives, sequential preparations, see G03AB.<br />

G03G GONADOTROPINS AND OTHER OVULATION STIMULANTS<br />

The <strong>DDD</strong>s are based on the initial treatment of anovulation.<br />

G03GA Gonadotropins<br />

This group comprises both naturally occurring gonad-stimulating<br />

hormones <strong>and</strong> synthetic ovulation stimulants. The combination of<br />

Follicle Stimulating Hormone <strong>and</strong> Luteinizing Hormone is classified in<br />

G03GA30.<br />

G03GB Ovulation stimulants, synthetic<br />

G03H ANTIANDROGENS<br />

G03HA Anti<strong>and</strong>rogens, plain<br />

Finasteride used <strong>for</strong> treatment of benign prostatic hypertrophy is<br />

classified in G04CB.<br />

The <strong>DDD</strong>s are based on the treatment of hypersexualism.<br />

G03HB Anti<strong>and</strong>rogens <strong>and</strong> estrogens<br />

This group comprises all combinations of cyproterone <strong>and</strong> estrogen<br />

regardless of indication.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!